Lakefront Biotherapeutics NVGLPGF 62 Days Inventory is 384.87 as of Mar. 2026, which is 30% below its 10-year median of 553.74. GuruFocus rates GLPGF with a GF Score™ of 62/100 and a GF Value™ of $113.04 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Lakefront Biotherapeutics NV ranks worse than 81.03% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lakefront Biotherapeutics NV's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.24.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lakefront Biotherapeutics NV's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 3.12.
Lakefront Biotherapeutics NV (OTCPK:GLPGF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lakefront Biotherapeutics NV's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lakefront Biotherapeutics NV's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lakefront Biotherapeutics NV Days Inventory Related Terms
Lakefront Biotherapeutics NV Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GLPGF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Lakefront Biotherapeutics NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lakefront Biotherapeutics NV Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lakefront Biotherapeutics NV's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lakefront Biotherapeutics NV's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lakefront Biotherapeutics NV (GLPGF) has a Days Inventory of 384.87 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lakefront Biotherapeutics NV and its competitors. This is 30% below median its historical median of 553.74. Over the past decade, Lakefront Biotherapeutics NV's Days Inventory has ranged from 452.23 to 655.24. According to the industry distribution chart, Lakefront Biotherapeutics NV ranks #517 out of 638 companies in the Biotechnology industry, placing it in the top 81%.
Is Lakefront Biotherapeutics NV's Days Inventory too high?
Lakefront Biotherapeutics NV's current Days Inventory of 384.87 is 30% below median its 10-year median of 553.74. Over the past 10 years, this metric has ranged from a low of 452.23 to a high of 655.24. The Biotechnology industry median Days Inventory is 183.88. Lakefront Biotherapeutics NV's value of 384.87 is 109.3% above this industry median. Based on the distribution chart, Lakefront Biotherapeutics NV ranks #517 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lakefront Biotherapeutics NV has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lakefront Biotherapeutics NV's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lakefront Biotherapeutics NV ranks #517 out of 638 companies for Days Inventory. This places Lakefront Biotherapeutics NV in the lower half of its industry. The industry median Days Inventory is 183.88. Lakefront Biotherapeutics NV's value of 384.87 is 109.3% above this benchmark. Historically, Lakefront Biotherapeutics NV's own Days Inventory has ranged from 452.23 to 655.24 over the past decade. While the company's 10-year median is 553.74 vs. the industry median of 183.88, Lakefront Biotherapeutics NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lakefront Biotherapeutics NV's current Days Inventory of 384.87 is 109.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lakefront Biotherapeutics NV and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lakefront Biotherapeutics NV's current Days Inventory is 384.87, which is 30% below median its own 10-year median of 553.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lakefront Biotherapeutics NV stock overvalued right now?
Based on GuruFocus' analysis, Lakefront Biotherapeutics NV (GLPGF) is currently considered Possible Value Trap. The stock's GF Value™ is $113.04, compared to a current price of $28.08 — trading 75.2% below its estimated fair value. The current Days Inventory is 384.87, which is 30% below median its 10-year median of 553.74 and 109.3% above the Biotechnology industry median of 183.88. Lakefront Biotherapeutics NV's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lakefront Biotherapeutics NV (GLPGF), the current Days Inventory is 384.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lakefront Biotherapeutics NV (GLPGF) Overvalued in 2026?
Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued.
The current stock price of $28.08 is trading 75.2% below its estimated GF Value™ of $113.04.
GuruFocus considers Lakefront Biotherapeutics NV to be Possible Value Trap.
Key valuation signals for GLPGF:
Days Inventory: 384.87 (30% below median its 10-year median of 553.74)
GF Value™: $113.04 vs. price of $28.08 (75.2% below fair value)
Industry Position: 109.3% above the Biotechnology median (#517 of 638)
No single metric tells the full story. See the GLPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
62GF Score
Get the complete analysis for GLPGF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLPGF has been successfully added to your 
